semaglutide 6mg vial Injectable – 6 mg/mL This medication is used with a doctor Semaglutide Oral

The landmark SELECT trial demonstrated that weekly semaglutide 2.4 mg reduces major cardiovascular events by 20% in people with obesity or overweight and established heart diseaseeven in those without diabetes.[1] This finding represents a paradigm shift in cardiovascular prevention, as it's the first time a weight-loss medication has been proven to directly reduce heart attacks, strokes, and cardiovascular deaths

13-16 weeks : After assessment, your doctor will escalate the dosage to 8 mg once weekly for the next 4 weeks 17-21 weeks : If your body tolerates 8 mg for 4 weeks, your doctor will increase the dose to 12 mg once weekly onwards

Once you reach effective dose, weight loss continues at 1-2 pounds weekly as long as calorie deficit persists

Serving all of Orange County Newport Beach, Irvine, Costa Mesa, Anaheim, Fountain Valley

2020;161(2):bqz046